You can buy or sell ChemoCentryx and other stocks, options, ETFs, and crypto commission-free!
ChemoCentryx, Inc. Common Stock, also called ChemoCentryx, is a biopharmaceutical company engages in the development and commercialization of medicines. Read More It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.
Mountain View, California
52 Week High
52 Week Low
Seeking AlphaMar 12
ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results - Earnings Call Transcript
ChemoCentryx, Inc. (NASDAQ:CCXI) Q4 2018 Earnings Conference Call March 11, 2019 5:00 PM ET Company Participants William Slattery - Investor Relations, Burns McClellan Inc. Thomas Schall - Chairman, President and Chief Executive Officer Susan Kanaya - Executive Vice President, Chief Financial and Administrative Officer and Secretary Conference Call Participants Lina Kaminski - Canaccord Genuity LLC Steven Seedhouse - Raymond James & Associates, Inc. Dae Gon Ha - SVB Leerink LLC Edward Tenthoff - Pi...
The Motley FoolMar 12
ChemoCentryx (CCXI) Q4 2018 Earnings Conference Call Transcript
CHEMOCENTRYX INC (NASDAQ:CCXI) Q4 2018 Earnings Conference Call , 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon, and welcome to the ChemoCentryx Fourth Quarter and Full Year 2018 Financial Results Conference Call. At this time, all participants on a listen-only mode. Later, we'll conduct a question-and-answer session. As a reminder, this conference will be recorded. I would now like turn the call over to your host, Bill Sl...
-$0.27 per share
-$0.21 per share